Opinion

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Opinion

We should never stop our efforts to provide the right patient with the right medicine at the right time

Photo from Matthijs Van Meerveld/Twitter

Jun 14, 2023, 12:42

We should never stop our efforts to provide the right patient with the right medicine at the right time

According to Matthijs Van Meerveld, “The right medicine for the right patient at the right time is a notion all stakeholders easily subscribe to, but it is far from easy to achieve this in practice. At Menarini Stemline our rapidly growing team of decidated pharma professionals is committed to addressing unmet needs in hematology with our medicines for the treatment of multiple myeloma and the rare disease Blastic plasmacytoid dendritic cell neoplasm (BPDCN). The EHA congress in Frankfurt provided an excellent opportunity to enhance our understanding of the optimal treatment of people living with these diseases, and to forge collaborations on advancing access to treatment. The ever evolving science is breathtaking, and we should never stop our efforts to provide the right patient with the right medicine at the right time”.

Source:

BPDCN Hematology Matthijs Van Meerveld Menarini Stemline

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Science

Dec 21, 2024, 13:18

Ruzanna Papyan: The Impact of Telemedicine on Improving Soft Tissue and Bone Tumor Management in Armenia

Science

Dec 21, 2024, 13:12

Myeloma Paper of the Day, December 21st, suggested by Robert Orlowski

Blog

Dec 21, 2024, 13:06

Varsha Gupta: Fertility preservation causes no significant delay in cancer treatment initiation and outcomes

Cancer Types

Dec 21, 2024, 13:05

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Insight

Dec 21, 2024, 12:45

Practical treatment strategies and novel therapies for HR positive/HER2 negative advanced breast cancer

Insight

Dec 21, 2024, 12:39

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Blog

Dec 21, 2024, 12:18

NCI Symposium on Translational Technology for Global Health

Blog

Dec 21, 2024, 12:14

Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan

Blog

Dec 21, 2024, 11:52

Gevorg Tamamyan's first message as New POEM President

Blog

Dec 21, 2024, 11:30

Kyaw Thein: Tissue-Agnostic Drug Development in Cancer

Dialogues

Dec 21, 2024, 11:29

Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian

Blog

Dec 21, 2024, 11:27

Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona